Related Experiment Video
Updated: May 5, 2026
07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
12.3K
How melanoma cells evade trail-induced apoptosis
1Immunology and Oncology Unit, Newcastle, New South Wales, Australia. Peter.Hersey@newcastle.edu.au
Nature Reviews. Cancer
|March 22, 2002
Summary
Chemotherapy and natural defenses kill melanoma via mitochondrial pathways. Melanoma survival is due to anti-apoptotic mechanisms, which researchers aim to overcome for improved cancer treatment.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Chemotherapy and natural immune responses target melanoma cells through common mitochondrial pathways.
- Apoptosis, or programmed cell death, is the primary mechanism of melanoma cell elimination.
- Melanoma cells develop resistance to apoptosis, enabling tumor survival within the host.
Purpose of the Study:
- To investigate the specific anti-apoptotic mechanisms employed by melanoma cells.
- To identify strategies for bypassing these resistance mechanisms.
- To enhance the efficacy of melanoma treatments.
Main Methods:
- The study likely involves molecular biology techniques to analyze cellular pathways.
- Investigating gene and protein expression related to apoptosis resistance.
- Exploring potential therapeutic targets to inhibit these survival mechanisms.
Main Results:
- The research aims to elucidate the key molecular players in melanoma's anti-apoptotic defenses.
- Identifying vulnerabilities in these resistance pathways.
- Providing a basis for novel therapeutic interventions.
Conclusions:
- Understanding melanoma's anti-apoptotic mechanisms is crucial for overcoming treatment resistance.
- Targeting these survival pathways offers a promising strategy to improve patient outcomes.
- Further research is needed to translate these findings into clinical applications.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
01:17The Extrinsic Apoptotic Pathway
6.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
01:31The Intrinsic Apoptotic Pathway
6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
01:30Skin Cancer
5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
01:22Cellular Injury V: Apoptosis and Autophagy
99
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
99